[Immune response to hepatitis B vaccine in neonates born to mothers with various infection status of hepatitis B virus]. 1989

S R Yin

Hepatitis B (HB) vaccine induced high levels of antibodies against HB surface antigen (HBsAg) in 161 neonates. Seven months after the first vaccination, 100.0 percent of the neonates who received 20 micrograms vaccine or 97.3 percent of those who got 10 micrograms vaccine developed anti-HBs with GMT of 1:448.9 or 1:217.8, respectively. HBV infection status of mothers were closely related to immune responses to hepatitis B vaccine in their babies. The babies born to mothers who were only anti-HBs positive had the strongest immune response, and their seroconversion rate and GMT of anti-HBs were 100.0% and 1:670.4, respectively. The weakest response was observed in babies born to mothers who were HBsAg carriers (75.0%, 1:40.3), or only anti-HBc positive (100.0%, 1:28.5), especially those who were positive for HBsAg and HBeAg. The intermediate response was found in babies born to mothers who were negative for all the HBV markers (100.0%, 1:376.4), or positive for both anti-HBs and anti-HBc (100.0%, 1:218.2). It is postulated that some genetic factor and the existence of HBV in mothers may play important roles in immune response to HB vaccine in their babies.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B

Related Publications

S R Yin
June 1981, Wiadomosci lekarskie (Warsaw, Poland : 1960),
S R Yin
January 1982, Lancet (London, England),
S R Yin
March 1991, The Southeast Asian journal of tropical medicine and public health,
S R Yin
September 2017, Pediatrics international : official journal of the Japan Pediatric Society,
Copied contents to your clipboard!